Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Przespolewski A, Goldberg AD, Talati C, Fazal S, Vachhani P, Sanikommu SR, Thota S, Waksal J, Ball B, Famulare C, Stahl M, Baron J, Griffiths EA, Thompson JE, Sweet K, Wang ES. Przespolewski A, et al. Among authors: griffiths ea. Blood. 2023 Mar 23;141(12):1489-1493. doi: 10.1182/blood.2022016678. Blood. 2023. PMID: 36493344 Free article. No abstract available.
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age.
Vigil CE, Tan W, Deeb G, Sait SN, Block AW, Starostik P, Griffiths EA, Thompson JE, Greene JD, Ford LA, Wang ES, Wetzler M. Vigil CE, et al. Among authors: griffiths ea. Leuk Res. 2013 Nov;37(11):1468-71. doi: 10.1016/j.leukres.2013.07.036. Epub 2013 Aug 15. Leuk Res. 2013. PMID: 24011826 Free PMC article. Clinical Trial.
Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia.
Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M. Lee HJ, et al. Among authors: griffiths ea. Cancer. 2014 Feb 15;120(4):521-9. doi: 10.1002/cncr.28368. Epub 2013 Oct 25. Cancer. 2014. PMID: 24166051 Free PMC article.
Omacetaxine mepesuccinate in chronic myeloid leukemia.
Al Ustwani O, Griffiths EA, Wang ES, Wetzler M. Al Ustwani O, et al. Among authors: griffiths ea. Expert Opin Pharmacother. 2014 Nov;15(16):2397-405. doi: 10.1517/14656566.2014.964642. Expert Opin Pharmacother. 2014. PMID: 25301179 Review.
How we will treat chronic myeloid leukemia in 2016.
Talati C, Ontiveros EP, Griffiths EA, Wang ES, Wetzler M. Talati C, et al. Among authors: griffiths ea. Blood Rev. 2015 Mar;29(2):137-42. doi: 10.1016/j.blre.2014.12.003. Epub 2014 Dec 17. Blood Rev. 2015. PMID: 25555325 Free PMC article. Review.
325 results